American Society of Hirudotherapy

Rickettsia japonica infection after land leech bite, Japan

Case report published in Emerg Infect Dis (2019)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportSafety & Infection ControlSando E et al. · Emerging infectious diseases, 2019

Abstract

We report a case of Rickettsia japonica infection in an 81-year-old man in central Japan. The patient had fever, rash, and an eschar but no evidence of a tick bite. His symptoms began 8 days after a land leech bite. The land leech is a potential vector of R. japonica.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsLetterResearch Support, Non-U.S. Gov't
Indexed MeSH termsAged, 80 and overAnimalsBiomarkersBites and StingsExanthemaFluorescent Antibody TechniqueHumansJapanLeechesMalePolymerase Chain ReactionRickettsia

Summary

81-year-old man in central Japan with fever, rash, and eschar 8 days after land-leech bite, confirmed Rickettsia japonica infection. Land leech identified as potential vector.

Why This Matters for Hirudotherapy

This case report describes an 81-year-old man in central Japan who developed Rickettsia japonica infection (fever, rash, eschar) with symptom onset eight days after a land leech bite and no evidence of a tick bite. The authors propose the land leech as a potential vector of R. japonica. This relates to ASH's domain only as documentation of an infectious complication following leech exposure, contributing to awareness of risks associated with leech bites. The case involves a wild land leech bite, not therapeutic hirudotherapy, and does not address the medicinal leech secretome, anticoagulant activity, or controlled leech application. It is a single case report establishing only a possible vector relationship.

Citation

Rickettsia japonica infection after land leech bite, Japan.

Sando E et al. · Emerging infectious diseases, 2019

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.